Moleculin Biotech Inc.

01/08/2025 | Press release | Distributed by Public on 01/08/2025 07:31

Moleculin Highlights Development Progress of Annamycin, Phase 2 Data Outperforms Billion-Dollar Assets in AML, Phase 3 Data Readouts in 2025 & 2026

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.